Fintel reports that on February 20, 2025, BMO Capital downgraded their outlook for SolarEdge Technologies (NasdaqGS:SEDG) ...

BMO Capital lowered the firm’s price target on Salesforce (CRM) to $375 from $425 and keeps an Outperform rating on the shares. The firm ...

BMO Capital analyst Kelly Bania raised the firm’s price target on Sprouts Farmers Market (SFM) to $180 from $140 and keeps a Market Perform ...

WSP Global (TSE:WSP – Get Free Report) had its price objective hoisted by equities researchers at BMO Capital Markets from ...

Equities research analysts at BMO Capital Markets started coverage on shares of Coeur Mining (NYSE:CDE – Get Free Report) in ...

Net lease REIT W. P. Carey (NYSE:WPC) was upgraded at BMO Capital Markets on factors such as growth and incremental cost of capital.

Jennifer Lee, Senior Economist at BMO Capital Markets, discusses President Donald Trump's tariff threats and the potential ...

BMO Capital raised the firm’s price target on DTE Energy (DTE) to $135 from $125 and keeps a Market Perform rating on the ...

Investors have no practical way to evaluate the effectiveness of initiatives from the Elon Musk-led entity known as the Department of Government Efficiency, and it’s hard to see any clarity for the ...

Tuesday, BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal ...

On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...